Published in AIDS Weekly, March 28th, 2011
"CXCL12 has a direct growth and survival-promoting effect for various cancer cells and enhances moreover tumor angiogenesis by...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.